MedTrace Logo

CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis

NCT04206436 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2025-10-02

No results posted yet for this study

Summary

Study is looking at the effects of cystic fibrosis treatment on bone muscle.

Conditions

Interventions

DRUG

Cftr Modulators

CFTR modulators are drugs used to treat cystic fibrosis

Sponsors & Collaborators

  • Cystic Fibrosis Foundation

    collaborator OTHER

  • Indiana University

    lead OTHER

Principal Investigators

  • Erik A Imel, MD · Indiana University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-18
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04206436 on ClinicalTrials.gov